WallStreetZenWallStreetZen

NASDAQ: RSLS
Reshape Lifesciences Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

RSLS past revenue growth

How has RSLS's revenue growth performed historically?
Company
-22.79%
Industry
9.47%
Market
17.2%
RSLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RSLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RSLS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RSLS earnings and revenue history

Current Revenue
$8.7M
Current Earnings
-$11.4M
Current Profit Margin
-131.2%

RSLS Return on Equity

Current Company
-187.9%
Current Industry
10.5%
Current Market
188%
RSLS's Return on Equity (-187.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RSLS announces earnings.

RSLS Return on Assets

Current Company
-97.5%
Current Industry
5.3%
RSLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RSLS Return on Capital Employed

Current Company
-164.99%
Current Industry
8.3%
RSLS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RSLS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RSLS$8.68M-$11.21M-$11.39M-0.95%N/A
VTAK$442.00k-$68.50M-$71.37M-41.14%N/A
HSDT$644.00k-$8.89M-$8.85M+6.14%N/A
AEMD$574.25k-$11.89M-$12.25M+20.67%N/A
BIOL$49.16M-$15.44M-$37.62M+1.27%N/A
View Top Medical Device Stocks

RSLS earnings dates

Next earnings date
May 13, 2024

Reshape Lifesciences Earnings & Revenue FAQ

What were RSLS's earnings last quarter?

Reshape Lifesciences (NASDAQ: RSLS) reported Q4 2023 earnings per share (EPS) of $1.54, up 104.39% year over year. Total Reshape Lifesciences earnings for the quarter were -$1.70 million. In the same quarter last year, Reshape Lifesciences's earnings per share (EPS) was -$35.11.

If you're new to stock investing, here's how to buy Reshape Lifesciences stock.

What was RSLS's earnings growth in the past year?

As of Q2 2024, Reshape Lifesciences's earnings has grown year over year. Reshape Lifesciences's earnings in the past year totalled -$11.39 million.

What is RSLS's earnings date?

Reshape Lifesciences's earnings date is Invalid Date. Add RSLS to your watchlist to be reminded of RSLS's next earnings announcement.

What was RSLS's revenue last quarter?

Reshape Lifesciences (NASDAQ: RSLS) reported Q4 2023 revenue of $1.98 million up 36.27% year over year. In the same quarter last year, Reshape Lifesciences's revenue was $3.11 million.

What was RSLS's revenue growth in the past year?

As of Q2 2024, Reshape Lifesciences's revenue has grown -22.79% year over year. This is 32.26 percentage points lower than the US Medical Devices industry revenue growth rate of 9.47%. Reshape Lifesciences's revenue in the past year totalled $8.68 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.